Catherine A. Sheils, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchopulmonary Dysplasia | 12 | 2023 | 306 | 1.890 |
Why?
|
Vital Capacity | 2 | 2021 | 922 | 0.620 |
Why?
|
Forced Expiratory Volume | 2 | 2021 | 1741 | 0.530 |
Why?
|
Infant, Premature | 11 | 2023 | 2041 | 0.360 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1527 | 0.300 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2020 | 363 | 0.280 |
Why?
|
Oximetry | 2 | 2020 | 467 | 0.270 |
Why?
|
Premature Birth | 3 | 2023 | 1713 | 0.260 |
Why?
|
Respiratory Function Tests | 5 | 2021 | 1613 | 0.250 |
Why?
|
Infant, Newborn | 17 | 2023 | 25575 | 0.220 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2020 | 43 | 0.180 |
Why?
|
Cystic Fibrosis | 4 | 2007 | 1178 | 0.180 |
Why?
|
Respiration Disorders | 1 | 2023 | 370 | 0.180 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2019 | 116 | 0.180 |
Why?
|
Adolescent Development | 1 | 2021 | 277 | 0.150 |
Why?
|
Infant | 14 | 2023 | 35070 | 0.140 |
Why?
|
Sputum | 3 | 2005 | 474 | 0.140 |
Why?
|
Fetal Therapies | 1 | 2016 | 100 | 0.130 |
Why?
|
Bronchitis | 1 | 1996 | 201 | 0.130 |
Why?
|
Lung | 3 | 2021 | 9826 | 0.120 |
Why?
|
Actins | 2 | 2005 | 2120 | 0.120 |
Why?
|
Gestational Age | 4 | 2023 | 3490 | 0.110 |
Why?
|
Child | 16 | 2023 | 77478 | 0.100 |
Why?
|
Deoxyribonuclease I | 2 | 2005 | 228 | 0.090 |
Why?
|
Outpatients | 3 | 2023 | 1483 | 0.090 |
Why?
|
Morbidity | 3 | 2022 | 1767 | 0.090 |
Why?
|
Particulate Matter | 1 | 2021 | 2523 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2021 | 13921 | 0.090 |
Why?
|
Child Development | 1 | 2021 | 2222 | 0.090 |
Why?
|
Patient Discharge | 4 | 2023 | 3300 | 0.080 |
Why?
|
Hernia, Diaphragmatic | 2 | 2007 | 250 | 0.080 |
Why?
|
Survivors | 2 | 2016 | 2286 | 0.080 |
Why?
|
Actinomycetales | 1 | 2007 | 31 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2023 | 77098 | 0.080 |
Why?
|
Air Pollution | 1 | 2021 | 2284 | 0.080 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 1989 | 171 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2016 | 1348 | 0.070 |
Why?
|
Environmental Exposure | 1 | 2021 | 4231 | 0.070 |
Why?
|
Polyglutamic Acid | 1 | 2005 | 45 | 0.070 |
Why?
|
Gelsolin | 3 | 2005 | 190 | 0.060 |
Why?
|
Pulmonary Ventilation | 1 | 2007 | 372 | 0.060 |
Why?
|
Child, Preschool | 7 | 2022 | 40955 | 0.060 |
Why?
|
Congenital Abnormalities | 1 | 1989 | 707 | 0.060 |
Why?
|
Rheology | 1 | 2004 | 345 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2014 | 2566 | 0.060 |
Why?
|
DNA | 2 | 2005 | 7289 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 40450 | 0.060 |
Why?
|
Humans | 26 | 2023 | 742088 | 0.050 |
Why?
|
Child Day Care Centers | 1 | 2022 | 123 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 12730 | 0.050 |
Why?
|
Altitude | 1 | 2021 | 161 | 0.050 |
Why?
|
Humidity | 1 | 2021 | 197 | 0.050 |
Why?
|
Female | 13 | 2023 | 379592 | 0.040 |
Why?
|
Nitrogen Dioxide | 1 | 2021 | 490 | 0.040 |
Why?
|
Male | 12 | 2023 | 349538 | 0.040 |
Why?
|
Tracheostomy | 1 | 2021 | 400 | 0.040 |
Why?
|
Steroids | 1 | 2022 | 931 | 0.040 |
Why?
|
Barotrauma | 1 | 2016 | 37 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1661 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2207 | 0.030 |
Why?
|
Viscosity | 2 | 2005 | 328 | 0.030 |
Why?
|
Air Pollution, Indoor | 1 | 2021 | 855 | 0.030 |
Why?
|
Allergens | 1 | 2021 | 1314 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2935 | 0.030 |
Why?
|
Elasticity | 2 | 2005 | 657 | 0.030 |
Why?
|
Peptides | 1 | 2005 | 4392 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 9941 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2021 | 2128 | 0.030 |
Why?
|
Home Care Services | 1 | 2018 | 602 | 0.030 |
Why?
|
Polysomnography | 1 | 2018 | 1772 | 0.030 |
Why?
|
Globins | 1 | 1992 | 415 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2022 | 1895 | 0.020 |
Why?
|
Lung Diseases | 1 | 2001 | 1884 | 0.020 |
Why?
|
Critical Illness | 1 | 2023 | 2665 | 0.020 |
Why?
|
Fetal Hemoglobin | 1 | 1992 | 341 | 0.020 |
Why?
|
Body Weight | 1 | 2020 | 4664 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3937 | 0.020 |
Why?
|
X Chromosome | 1 | 1992 | 815 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 1996 | 2699 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9305 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39004 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53187 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8077 | 0.020 |
Why?
|
Anions | 1 | 2005 | 133 | 0.020 |
Why?
|
Dithiothreitol | 1 | 2004 | 101 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12773 | 0.020 |
Why?
|
Time Factors | 2 | 2018 | 40054 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 85649 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19862 | 0.020 |
Why?
|
Parents | 1 | 2018 | 3387 | 0.020 |
Why?
|
Shear Strength | 1 | 2004 | 165 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 1992 | 1017 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18355 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 56350 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10232 | 0.010 |
Why?
|
United States | 2 | 2022 | 69693 | 0.010 |
Why?
|
Solubility | 1 | 2005 | 1083 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2007 | 1574 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21719 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8297 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2007 | 2027 | 0.010 |
Why?
|
Asthma | 1 | 2021 | 5955 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 72145 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8662 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2253 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2007 | 1871 | 0.010 |
Why?
|
Chronic Disease | 1 | 1996 | 9144 | 0.010 |
Why?
|
Child Abuse | 1 | 1989 | 1030 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23320 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29087 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1989 | 2522 | 0.010 |
Why?
|
Bacteria | 1 | 2005 | 2102 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2016 | 15244 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2016 | 62966 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 29010 | 0.010 |
Why?
|
Chromosome Banding | 1 | 1992 | 278 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1992 | 768 | 0.010 |
Why?
|
Regression Analysis | 1 | 2001 | 6452 | 0.010 |
Why?
|
Survival Analysis | 1 | 2001 | 10248 | 0.000 |
Why?
|
Reference Values | 1 | 1992 | 4982 | 0.000 |
Why?
|
Pedigree | 1 | 1992 | 4646 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1992 | 4742 | 0.000 |
Why?
|
Sex Characteristics | 1 | 1992 | 2585 | 0.000 |
Why?
|
Adult | 2 | 2007 | 213712 | 0.000 |
Why?
|
Phenotype | 1 | 1992 | 16331 | 0.000 |
Why?
|